Maravai Lifesciences Holdings Inc Cl A (MRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 185,743 | 259,185 | 288,945 | 883,001 | 799,240 |
| Cost of Goods | 151,753 | 150,876 | 148,743 | 168,957 | 140,561 |
| Gross Profit | 33,990 | 108,309 | 140,202 | 714,044 | 658,679 |
| Operating Expenses | 250,009 | 344,802 | 172,593 | 140,785 | 104,595 |
| Operating Income | -215,266 | -235,617 | -31,648 | 574,216 | 554,645 |
| Interest Expense | 26,992 | 47,700 | 45,892 | 20,414 | 30,260 |
| Other Income | 7,284 | 21,835 | 695,276 | -2,330 | 6,380 |
| Pre-tax Income | -234,974 | -261,482 | 617,736 | 551,472 | 530,765 |
| Income Tax | -4,212 | -1,860 | 756,111 | 60,809 | 61,515 |
| Net Income Continuous | -230,762 | -259,622 | -138,375 | 490,663 | 469,250 |
| Minority Interests | -99,989 | -114,776 | -19,346 | 270,458 | 287,213 |
| Net Income | $-130,773 | $-144,846 | $-119,029 | $220,205 | $182,037 |
| EPS Basic Total Ops | -0.90 | -1.05 | -0.90 | 1.67 | 1.59 |
| EPS Basic Continuous Ops | -1.60 | -1.88 | -1.05 | 3.73 | 4.09 |
| EPS Diluted Total Ops | -0.90 | -1.05 | -0.90 | 1.67 | 1.56 |
| EPS Diluted Continuous Ops | -1.60 | -1.88 | -1.05 | 1.92 | 1.82 |
| EPS Diluted Before Non-Recurring Items | -0.49 | -0.41 | -0.22 | 1.80 | 1.60 |
| EBITDA(a) | $-153,140 | $-175,856 | $20,062 | $615,107 | $590,865 |